Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

232 requests
Make a request to this authority
FOI Request - Complaints against slimming aids for calendar year 2017
Response by Medicines and Healthcare products Regulatory Agency to Rhiannondavies on .

Partially successful.

5^th April 2018 Rhiannon Davies [1][FOI #469135 email]   Dear Requestor,   REF:  FOI 18/114   Thank you for your communication to the M...
Domain suspension requests
Response by Medicines and Healthcare products Regulatory Agency to Open Rights Group on .

Refused.

  4^th April 2018   Dear Mr Killock         Thank you for your email.   Please find your internal review attached.          Kind Re...
Number of adverse incident reports for implantable Mesh and who reported
Response by Medicines and Healthcare products Regulatory Agency to Karen Preater on .

Successful.

MHRA reference: FOI 18/075 Dear Ms Preater, Thank you for your email of 17 March 2018 asking for clarification on our previous reply. We can confirm...
Animal research
Response by Medicines and Healthcare products Regulatory Agency to Eithne Gallagher on .

Awaiting classification.

Our Ref: FOI 18/136          Dear Eithne Gallagher,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000          Thank you for your enquir...
Documents for manufacturing of Liothyronine.
Response by Medicines and Healthcare products Regulatory Agency to Kathryn Potter on .

Successful.

Dear Kathryn Potter,   RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 11 February 2...
Comparison of MHRA revised standards for Liothyronine manufacture with those of other regulators
Response by Medicines and Healthcare products Regulatory Agency to Mike Maguire on .

Successful.

Dear Mr Maguire,         Thank you for your email.   Please find attached the response to your FOI request which was sent to you on 7^th March...
Liothyronine Concordia
Response by Medicines and Healthcare products Regulatory Agency to helga Wright on .

Successful.

Dear Helga Wright,   RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 10 February and...
Concordia International 6000% increase in price of Liothyronine tablets
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Successful.

Dear Linda Sanday,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 6 Februar...
How does the MHRA monitor Liothyronine T3 manufacturers' quality control
Response by Medicines and Healthcare products Regulatory Agency to Mike Maguire on .

Successful.

Dear Mr Maguire,   RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000   Thank you for your enquiries which we received on 12 February and 1...
Query regarding number of hypothyroid patients in 2010
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Long overdue.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Number of adverse incidents reported from hernia mesh
Response by Medicines and Healthcare products Regulatory Agency to Karen Preater on .

Successful.

Dear Karen Preater, Thank you for your request for clarification. Apologies for any confusion caused. Where the number of reports are low (less than...
Liothyronine Concordia
Response by Medicines and Healthcare products Regulatory Agency to helga Wright on .

Long overdue.

Our Ref: FOI 18/068         Dear Ms Wright,         RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000         Thank you for your enquiries wh...
Cost implications in the manufacturing of Liothyronine tablets
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Awaiting classification.

Dear Ms Linda Sanday, Thank you for your emails which we have referred onward for consideration. We will respond to you as soon as possible. The ref...
Lobbying by Pharmaceutical Companies
Response by Medicines and Healthcare products Regulatory Agency to Philip Deans on .

Successful.

FOI 16/263 10 May 2016 Dear Mr Deans, Thank you for your Freedom of Information Act (FOIA) request of 22nd April 2016, addressed to the Medicines an...
Minutes of the Committee On Human Medicines
Response by Medicines and Healthcare products Regulatory Agency to Angus Files on .

Successful.

FOI 17/553   Dear Mr Files,   Thank you for your email.   Please find attached the response to your FOI request.   Kind Regards   C...
Domain suspension requests
Response by Medicines and Healthcare products Regulatory Agency to Open Rights Group on .

Partially successful.

Dear Mr Killock,   REF:  FOI 17/513   Thank you for your communication to the MHRA in relation to a Freedom of Information request for informa...
Does donation of medcines to third world countries require a WDA license?
Response by Medicines and Healthcare products Regulatory Agency to Yinka Udueni on .

Awaiting classification.

Dear Yinka Udueni Thank you for your email. I would like to confirm you will need WDA licence to donate medicines to third world countries. Kind r...
Thimerosal In Vaccines After Manufacturing
Response by Medicines and Healthcare products Regulatory Agency to Angus Files on .

Partially successful.

FOI 17/474 Dear Mr Files, Thank you for your information request, dated 25th October, where you asked for information about whether thiomersal is use...
Product management
Response by Medicines and Healthcare products Regulatory Agency to Angus Files on .

Information not held.

Dear Angus Files,         Thank you.   Please find attached the response to your FOI request.      Kind regards, Customer Services Communications...
Request for number and names of ant idepressants with reported adverse effect
Response by Medicines and Healthcare products Regulatory Agency to susanne stevens on .

Successful.

FOI 17/482 Dear Ms Stevens, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Commun...
CPRD access
Response by Medicines and Healthcare products Regulatory Agency to Hal Hodson on .

Refused.

FOI17/435 and FOI17/462 Dear Mr Hodson, Thank you for your requests dated 29 September 2017 and 18 October 2017, we are combining our responses due...
Will Cavendish & Verily
Response by Medicines and Healthcare products Regulatory Agency to Hal Hodson on .

Successful.

FOI17/434 Dear Mr Hodson. Thank you for your request dated 29 September 2017 where you asked: In a recent FOI response (FOI 17/060), you withheld...
How many adverse incidents reports for surgical mesh devices in Wales
Response by Medicines and Healthcare products Regulatory Agency to Karen Preater on .

Successful.

MHRA reference: FOI 17/410   Dear Karen Preater,   Thank you for your information request for ‘the number of adverse incident (medical devices...
Increasing Use Of Dangerous Opiates
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Partially successful.

Dear James Kelly,         Thank you for your email. Please find attached your response.        Kind Regards, Customer Services Communications di...
Essure implant use in the UK
Response by Medicines and Healthcare products Regulatory Agency to Z. Tsjeng on .

Refused.

Dear Sir, Thank you for your recent email requesting information under our FOI scheme. You have requested information held by the Medicines and Healt...

Only requests made using WhatDoTheyKnow are shown. ?